ECZEMA

This study tracks 183 adults with moderate-to-severe atopic dermatitis (eczema) who take abrocitinib tablets daily for up to 24 months. Researchers want to see how well the drug clears skin and eases symptoms in real-life settings, not just in controlled trials. Participants can …

This study tests a new medication called IMG-007 in adults with moderate-to-severe eczema (atopic dermatitis). About 220 participants will receive either IMG-007 or a placebo to see if it safely reduces skin symptoms like redness and itching. The main goal is to measure improveme…

This study follows 200 people aged 12 and older with moderate-to-severe eczema who are starting a new prescription of abrocitinib. Researchers will track how much their skin improves over 12 months in real-world settings, not a controlled lab. The goal is to see how well the drug…

This study tests whether the medicine abrocitinib can safely improve moderate-to-severe eczema in children aged 6 to 12. About 150 children will be randomly assigned to receive either the study drug or a placebo for 16 weeks. The goal is to see if the medicine clears the skin and…

This study is testing whether giving pregnant women high doses of fish oil can reduce the risk of their children developing asthma or persistent wheezing in the first three years of life. The researchers are recruiting 2,000 pregnant women in Denmark who have low blood levels of …

This study is testing whether giving pregnant women higher doses of vitamin D than currently recommended can prevent asthma and persistent wheezing in their children during the first three years of life. Researchers will enroll 2,000 pregnant women in Denmark and follow their chi…

This study tests whether a spray made from ground cardamom and a harmless skin bacteria (Roseomonas mucosa) can improve eczema symptoms. About 120 people aged 2 and older with eczema will use the spray at home 2-3 times a week for 14 weeks. The goal is to see if it reduces rash a…

This study tests a new medicine called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 people will receive either the drug or a placebo to see if it reduces skin redness, swelling, and itching. The main goal is to measure improvement in eczem…

This early-stage study tests a new medicine called ARQ-234 in healthy people and those with moderate to severe eczema (atopic dermatitis). The main goals are to check safety and see if the drug can reduce skin symptoms like redness and itching. About 125 adults will take part, an…

This study tests a new daily pill, soquelitinib, in 200 adults with moderate to severe atopic dermatitis (eczema). Participants take the drug or a placebo for 12 weeks. Doctors track skin improvements and side effects to see if the drug is safe and works better than a dummy pill.

This study tests whether a daily probiotic drink can improve immune function and reduce skin inflammation in women aged 40-60 going through menopause. Participants will drink either a probiotic or a plain milk drink for 8 weeks. Researchers will measure immune aging, inflammation…

This study tests an experimental ointment called GX-03 in adults with moderate to severe eczema. About 110 participants will apply either GX-03 or a placebo cream daily for 8 weeks. Researchers will check if the treatment clears skin, reduces itch, and improves quality of life.

This study is testing whether a moisturizing lotion can safely improve eczema symptoms in adults with mild-to-moderate atopic eczema. Fifteen participants will use the lotion for 4 weeks, with skin checks at the start and end. The goal is to see if the lotion reduces redness, dry…

This study looks at whether giving parents personalized advice based on their baby's gut bacteria can improve gut health and lower the risk of conditions like eczema in infants born by C-section. Researchers will follow 250 babies from birth to age 2, comparing a group that gets …

This study collects blood, urine, and skin samples from 200 adults with cutaneous T-cell lymphoma, eczema, or atopic dermatitis. The samples are stored for current and future research to better understand these conditions. Participants must be 18 or older and have a confirmed dia…

This study looks at the tiny organisms living on human skin, like bacteria and fungi, to understand how they affect health and eczema. Researchers will compare healthy volunteers and people with moderate to severe eczema, aged 2 to 40. Participants provide skin swabs, scrapings, …

This study looks at how treatments for eczema (atopic dermatitis) change the types and amounts of bacteria on the skin. Researchers will compare skin samples from people with eczema and healthy volunteers over one year. The goal is to understand how treatments affect the skin's m…